Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00652808 | Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee | PHASE3 | COMPLETED | 265 | — | — | May 1, 2004 | Sep 1, 2004 | Apr 10, 2008 | 8 | South Korea |
| NCT00648258 | A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan | PHASE3 | COMPLETED | 130 | — | — | Jul 1, 2003 | Apr 1, 2004 | Dec 5, 2018 | 4 | Taiwan |
| Arm | Type | Description |
|---|---|---|
| Arm 1 | ACTIVE_COMPARATOR | - |
| Arm 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| valdecoxib | DRUG | valdecoxib 10 mg tablet by mouth once daily for 6 weeks |
| naproxen | DRUG | naproxen 500 mg capsule by mouth twice daily for 6 weeks |
Inclusion Criteria: * Korean outpatients with symptomatic radiologic evidence of OA of the knee (diagnosed according to the modified American College Rheumatology criteria) * Patient's Assessment of Arthritis Pain measurement of at least 40 mm on VAS * Patients had not received any NSAIDs or analge...